GENTILE, GIORGIO
GENTILE, GIORGIO
DIPARTIMENTO DI MEDICINA INTERNA (attivo dal 14/09/1994 al 31/12/2013)
Aliskiren versus ramipril in hypertension.
2010 P., Verdecchia; Angeli, Fabio; G., Mazzotta; P., Martire; M., Garofoli; Gentile, Giorgio; Reboldi, Gianpaolo
Angiotensin-converting enzyme inhibitors
2012 Gentile, Giorgio; Reboldi, Gianpaolo; Angeli, Fabio; G., Mazzotta; P., Verdecchia
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke.
2008 Angeli, Fabio; Gentile, Giorgio; Reboldi, Gianpaolo; P., Verdecchia
Benefits of more intensive versus less intensive blood pressure control. Updated trial sequential analysis
2022 Reboldi, G.; Angeli, F.; Gentile, G.; Verdecchia, P.
Beta-blockers and risk of all-cause mortality in non-cardiac surgery.
2010 Angeli, Fabio; P., Verdecchia; G., Karthikeyan; G., Mazzotta; S., Repaci; M. d., Pinto; Gentile, Giorgio; C., Cavallini; Reboldi, Gianpaolo
Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
2012 Verdecchia, P; Gentile, Giorgio; Angeli, Fabio; Reboldi, Gianpaolo
Blood pressure lowering in diabetic patients.
2012 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Ambrosio, Giuseppe; G., Mancia; P., Verdecchia
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials.
2009 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; P., Verdecchia
Comparative assessment of angiotensin receptor blockers in different clinical settings.
2009 P., Verdecchia; Angeli, Fabio; S., Repaci; G., Mazzotta; Gentile, Giorgio; Reboldi, Gianpaolo
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
2008 Reboldi, Gianpaolo; Angeli, Fabio; C., Cavallini; Gentile, Giorgio; G., Mancia; P., Verdecchia
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension: Prognostic Implications
2012 P., Verdecchia; Angeli, Fabio; G., Mazzotta; M., Garofoli; E., Ramundo; Gentile, Giorgio; Ambrosio, Giuseppe; Reboldi, Gianpaolo
Diabete Mellito Complicanze Cardiache e Renali (13 Lemmi)
2007 Reboldi, Gianpaolo; Gentile, Giorgio
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients
2011 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Ambrosio, Giuseppe; Mancia, G; Verdecchia, P.
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus.
2009 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; P., Verdecchia
Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring.
2009 P., Verdecchia; Angeli, Fabio; G., Mazzotta; Gentile, Giorgio; Reboldi, Gianpaolo
Home Blood Pressure Measurements Will or Will Not Replace 24-Hour Ambulatory Blood Pressure Measurement.
2009 P., Verdecchia; Angeli, Fabio; G., Mazzotta; Gentile, Giorgio; Reboldi, Gianpaolo
Microalbuminuria and hypertension.
2005 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Verdecchia, P.
Optimal therapy in hypertensive subjects with diabetes mellitus
2011 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Verdecchia, P.
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment.
2011 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Verdecchia, P.
Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease
2018 Angeli, Fabio; Gentile, Giorgio; Trapasso, Monica; Verdecchia, Paolo; Reboldi, Gianpaolo
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Aliskiren versus ramipril in hypertension. | 2010 | P., Verdecchia; Angeli, Fabio; G., Mazzotta; P., Martire; M., Garofoli; Gentile, Giorgio; Reboldi, Gianpaolo | |
Angiotensin-converting enzyme inhibitors | 2012 | Gentile, Giorgio; Reboldi, Gianpaolo; Angeli, Fabio; G., Mazzotta; P., Verdecchia | |
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke. | 2008 | Angeli, Fabio; Gentile, Giorgio; Reboldi, Gianpaolo; P., Verdecchia | |
Benefits of more intensive versus less intensive blood pressure control. Updated trial sequential analysis | 2022 | Reboldi, G.; Angeli, F.; Gentile, G.; Verdecchia, P. | |
Beta-blockers and risk of all-cause mortality in non-cardiac surgery. | 2010 | Angeli, Fabio; P., Verdecchia; G., Karthikeyan; G., Mazzotta; S., Repaci; M. d., Pinto; Gentile, Giorgio; C., Cavallini; Reboldi, Gianpaolo | |
Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers. | 2012 | Verdecchia, P; Gentile, Giorgio; Angeli, Fabio; Reboldi, Gianpaolo | |
Blood pressure lowering in diabetic patients. | 2012 | Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Ambrosio, Giuseppe; G., Mancia; P., Verdecchia | |
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. | 2009 | Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; P., Verdecchia | |
Comparative assessment of angiotensin receptor blockers in different clinical settings. | 2009 | P., Verdecchia; Angeli, Fabio; S., Repaci; G., Mazzotta; Gentile, Giorgio; Reboldi, Gianpaolo | |
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. | 2008 | Reboldi, Gianpaolo; Angeli, Fabio; C., Cavallini; Gentile, Giorgio; G., Mancia; P., Verdecchia | |
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension: Prognostic Implications | 2012 | P., Verdecchia; Angeli, Fabio; G., Mazzotta; M., Garofoli; E., Ramundo; Gentile, Giorgio; Ambrosio, Giuseppe; Reboldi, Gianpaolo | |
Diabete Mellito Complicanze Cardiache e Renali (13 Lemmi) | 2007 | Reboldi, Gianpaolo; Gentile, Giorgio | |
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients | 2011 | Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Ambrosio, Giuseppe; Mancia, G; Verdecchia, P. | |
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus. | 2009 | Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; P., Verdecchia | |
Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring. | 2009 | P., Verdecchia; Angeli, Fabio; G., Mazzotta; Gentile, Giorgio; Reboldi, Gianpaolo | |
Home Blood Pressure Measurements Will or Will Not Replace 24-Hour Ambulatory Blood Pressure Measurement. | 2009 | P., Verdecchia; Angeli, Fabio; G., Mazzotta; Gentile, Giorgio; Reboldi, Gianpaolo | |
Microalbuminuria and hypertension. | 2005 | Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Verdecchia, P. | |
Optimal therapy in hypertensive subjects with diabetes mellitus | 2011 | Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Verdecchia, P. | |
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment. | 2011 | Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Verdecchia, P. | |
Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease | 2018 | Angeli, Fabio; Gentile, Giorgio; Trapasso, Monica; Verdecchia, Paolo; Reboldi, Gianpaolo |